Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Hofer

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cardiovascular Drugs and Therapy|March 4, 2021
Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionPatrick Sulzgruber, Felix Hofer, Niema Kazem, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 22, 2019
Transcatheter versus surgical aortic valve replacement in low-risk patients: a meta-analysis of randomized trialsFelix Hofer, Christian Hengstenberg, Georg Goliasch, et al.
Thrombosis and Haemostasis|December 18, 2020
The Age-Specific Impact of Cellular Immunity on Long-Term Outcome after Acute Coronary SyndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
MMW Fortschritte Der Medizin|April 3, 2019
[Aortic valve disease]Jolanta M Siller-Matula, Felix Hofer, Georg Goliasch, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 15, 2020
Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategiesFelix Hofer, Niema Kazem, Andreas Hammer, et al.
European Heart Journal Open|August 3, 2022
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
Annals of Clinical Biochemistry|March 15, 2021
Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarctionFelix Hofer, Thomas Perkmann, Gloria Gager, et al.
Journal of Personalized Medicine|July 27, 2022
Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary InterventionEva Steinacher, Felix Hofer, Niema Kazem, et al.
Cardiovascular Drugs and Therapy|March 5, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery DiseaseFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Clinical Cardiology|October 19, 2021
The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategiesFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cardiovascular Drugs and Therapy|March 4, 2021
Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionPatrick Sulzgruber, Felix Hofer, Niema Kazem, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 22, 2019
Transcatheter versus surgical aortic valve replacement in low-risk patients: a meta-analysis of randomized trialsFelix Hofer, Christian Hengstenberg, Georg Goliasch, et al.
Thrombosis and Haemostasis|December 18, 2020
The Age-Specific Impact of Cellular Immunity on Long-Term Outcome after Acute Coronary SyndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
MMW Fortschritte Der Medizin|April 3, 2019
[Aortic valve disease]Jolanta M Siller-Matula, Felix Hofer, Georg Goliasch, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 15, 2020
Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategiesFelix Hofer, Niema Kazem, Andreas Hammer, et al.
European Heart Journal Open|August 3, 2022
The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndromeNiema Kazem, Felix Hofer, Lorenz Koller, et al.
Annals of Clinical Biochemistry|March 15, 2021
Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarctionFelix Hofer, Thomas Perkmann, Gloria Gager, et al.
Journal of Personalized Medicine|July 27, 2022
Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary InterventionEva Steinacher, Felix Hofer, Niema Kazem, et al.
Cardiovascular Drugs and Therapy|March 5, 2021
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery DiseaseFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Clinical Cardiology|October 19, 2021
The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategiesFelix Hofer, Niema Kazem, Ronny Schweitzer, et al.
Pageof 5